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ABSTRACT 
Objective: A new and powerful statistical approach known as the uncertainty profile concept has been suggested for both testing the validity and 
making easy and straightforward interpretation of results obtained during the validation of an analytical method. The main goal of this paper is to 
confirm the applicability of this new strategy for the validation of a commercial kit, microbiological method, for the enumeration of the 
Enterobacteriaceae in foods and the estimate of the measurement uncertainty by using the newly provided formula and without referring to any 
additional experiments. 
Methods: An innovative formula to assess the uncertainty by using validation data and without recourse to other additional experiments was 
proposed. The uncertainty was evaluated through the two-sided β-content, γ-confidence tolerance interval, which is computed with three manners: 
the Mee’s approach, the Generalized Pivotal Confidence, and the Modified Large Simple procedure 
Results: After the use of the three chemometric method of calculation of tolerance intervals, the obtained results with uncertainty profile show 
without doubt that the enumeration method is valid over the range of target values given that the upper and the lower 66.7 %-content, 90 %-
confidence tolerance limits have fallen within the two acceptance limits of±0.25 Log unit. If the β is stretched to 80 %-content, 90 %-confidence, the 
three computed tolerance intervals lead to different decisions. 
Conclusion: we have demonstrated the ability of the uncertainty profile to be used for testing the validity of enumeration method which represents 
the first application of an uncertainty profile to food microbiological methods, and provides good estimations of the uncertainty measurements for 
each concentration level. 
Keywords: Validation, Uncertainty profile, β-content-γ-confidence tolerance interval, Uncertainty measurement, Microbiological method 
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INTRODUCTION 
Actually, it is well known that the analytical, microbiological 
methods are very crucial on account of their role and efficacy to 
provide accurate quantification of the analyte in pharmaceutical and 
medical field. Concerning tests implemented, manufacturers must 
verify that their microbiological methods are applicable to analyze 
the pharmaceuticals or medical devices and then yields a confidence 
in the validity of analytical results that are provided to customers. 
An analytical measurement is a tool to make a suitable decision. 
Therefore, the effort must be heading essentially to the metrological 
quality of the measurements, which requires introducing two 
important concepts: analytical validation and estimation of 
measurement uncertainty. Then, to ensure an analytical 
measurement, the analyst is called to master both these concepts 
which are passages mandatory for all laboratories that are trying to 
be accredited according to ISO 17025 [2].  
Thus, the validation of a bioanalytical method is crucial since it is 
mandatory to prove that an alternative method is able actually to 
deliver results that can be interpreted in the same way as those 
obtained with the reference method. 
Otherwise, several papers like standards and guidelines have been 
published in order to propose a procedure for validating analytical and 
bioanalytical methods [3-9]. In general, they recommend checking a 
validation set of criteria that must be compared to threshold values. 
Although these documents have largely contributed to the 
advancement of the implementation of analytical validation, however, 
they have weaknesses on the conclusions of tests performed and as to 
aid in decision making related to acceptance limits defined for the use 
of an analytical procedure. In addition, the guide ISO 16140 [10], 
defined the final decision rules which are principally based on a set of 
null hypothesis tests, aiming to demonstrate that the estimated 
parameters for the alternative method do not differ significantly from 
those obtained with the reference method. This strategy presents 
many drawbacks that were extensively described in recent papers [11, 
12]. Consequently, the SFSTP published a guide entitled 
‘Harmonization of strategies for the validation of quantitative 
analytical procedures [3, 4] where a new interpretation strategy has 
been developed, called accuracy profile, based on global acceptance 
criteria so that such confusing conclusions can be avoided. This 
strategy of accuracy profile as a decision tool based on the concept of 
total error and uses the β-expectation tolerance interval. It has been 
proved its efficacy to select the most appropriate response function, to 
determine the limits of quantification and to assess the concentration 
range. In spite of its applicability and flexibility, this approach has 
shown, however, gaps in the estimation of measurement uncertainty 
[13-21]. Undoubtedly, measurement uncertainty is a crucial parameter 
which the estimation is considered as a major problem for every 
laboratory. So as to assist analysts, standards and guides have been 
published to assess the measurement uncertainty [22-26] such as the 
International Organization for Standardization (ISO) approach [24] 
(commonly known as “bottom-up” approach) and the Analytical 
Methods Committee [27] (commonly known as “top-down” approach). 
From ISO Guide, EURACHEM was conceived and adapted specifically 
for chemical measurements [28]. 
The implementation of the bottom-up approach to measurement 
uncertainty proposed by the GUM is hardly applicable for complex 
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analytical or bioanalytical methods because of the difficulty of 
constructing an uncertainty budget model [29-31]. The propagation 
of the uncertainties in this model following the law of error 
propagation is another difficulty. According to the EURACHEM guide 
[28], uncertainty can be evaluated from the validation data. Thus, 
research studies have been published and dedicated to the one and 
only main purpose of simplifying and evaluating the uncertainty of 
measurement from validation data [32-40]. Consequently, all 
researchers’ concentration was mainly to adopt a global, harmonic 
and easy to practice strategy to test the validity of an analytical 
method and to estimate the measurement uncertainty. 
In this paper, we try to show the applicability of a new analytical 
validation strategy and estimation of measurement uncertainty and 
expand its field of application by applying it to a biological matrix. 
This approach called the uncertainty profile was developed in our 
laboratory not simply to validate an analytical method but also to 
estimate the measurement uncertainty. This means that thanks to 
this approach, we can perform a full validation. 
It is based on the use the two sided β-content, γ-confidence 
tolerance interval in order to build a powerful graphical tool that 
allows simply making a decision about the validity of a bioanalytical 
method [14-21]. 
The present study aims to illustrate the validity of an alternative 
method for the quantitative enumeration of Enterobacteriaceae. 
Three Chemometrics methodologies are uncovered to build the β-
content, γ-confidence tolerance interval, namely: the Satterthwaite’s 
approximation, the GPQ method (generalized pivotal confidence) and 
the MLS procedure (modified large simple). Furthermore, we illustrate 
the applicability and flexibility of the uncertainty profile to assess the 
fitness of the purpose of analytical, microbiological methods [20]. 
METHODS AND EXPERIENCES 
Case study 
The 3M Petri film Enterobacteriaceae Count Plate is a sample-ready 
culture medium system applicable to the enumeration of 
Enterobacteriaceae in food products and the industrial environment. 
The measure and is colony-forming unit per gram (CFU/g). Indeed, 
two major features are met in the original application: the difficulty 
encountered in defining the measure and for microbiological methods; 
and the use of experimental data collected in the framework of a 
collaborative study instead of by a single laboratory. Actually, tests for 
Enterobacteriaceae are mandatory steps in the process hygiene for 
many foodstuffs [1]. Therefore, enumeration of Enterobacteriaceae in 
foods now shows evidence of increasing interest. 
Uncertainty assessment: new approach 
The uncertainty is a parameter associated with the result of a 
measurement that characterizes the dispersion of the values that 
could reasonably be attributed to the measure and. 
A simple and efficient procedure has recently made available to 
researchers to estimate the uncertainty of their analytical methods 
without restoring to other studies or experiments. Indeed, this 
approach is based only on the validation data and brings together 
two major objectives, the validation of analytical methods and 
estimation of measurement uncertainty. The estimation of the 
uncertainty is crucial for the interpretation of the results obtained 
and especially their comparisons with the statutorily above 
compliance limits. The declaration of an analytical result is 
incomplete without knowing the measurement uncertainty. Hence, 
ISO 17025 requires since 2001 for testing laboratories, to apply 
procedures for estimating uncertainty and to be able, if necessary, to 
be associated with the results returned [2]. Generally, the 
uncertainty is, as it is indicated in references [16, 17, 20], expressed 
by the following equations:  
U = Y� + t(υ)u(Z) EQ. 1 
L = Y� − t(υ)u(Z) EQ. 2 




 EQ. 3 
With:  
• U: is the upper β-content tolerance interval;  
• L: is the lower b-content tolerance interval;  
• t(υ) is the 1+γ
2
 quantile of Student t distribution with ν degrees of 
freedom. For balanced data, ν can be estimated by the 
Satterthwaite’s formula [41]. 
Construction of uncertainty profile 
The building strategy of uncertainty profile, which comes after 
computing the uncertainty through the equation (3), is based on the 
following expression:  
|Y� ± ku(Z)| ≤ λ EQ. 4 
Where 
• k is a coverage factor which depends to the level of confidence 
desired. For an approximate level of confidence of 95%, k =2. 
• Y� is the mean of results and λ is the acceptance limits. 
We can also build the uncertainty profile by the following 
expression:  
|bias ± ku(Z)| ≤ λ EQ. 5 
Where:  
bias = Y� − μT EQ. 6 
And µT is the true value 
To achieve the uncertainty profile, we have to respect the following 
steps [14-21] 
i. Choice of the appropriate acceptance limits taking into account 
the intended use of the method. 
ii. Generate all possible calibration models using the calibration data. 
iii. Calculation of the inverse predicted concentrations of all 
validation standards according to the selected calibration model. 
iv. Compute the two-sided β-content γ-confidence tolerance intervals 
for each level, according to one of three approaches proposed below. 
v. Determination of the uncertainty for each level using equation (3). 
vi. Construct the uncertainty profile according to equation (5) and 
make 2D-graphical representation results for the acceptability and 
uncertainty limits. 
vii. Compare the interval of uncertainty (L, U) to the acceptance limits 
(-λ, λ). 
viii. If (L, U) falls totally within (-λ, λ), the method is accepted; 
otherwise, the method is not valid. 
Tolerance intervals 
Before computing the uncertainty, we have to estimate the tolerance 
interval. Generally, two kinds of tolerance intervals are largely used, 
which are the β-expectation tolerance interval and β-content, γ-
confidence tolerance interval. In this section, our main interest lies 
in β-content, γ-confidence tolerance intervals which are also called 
guaranteed coverage tolerance intervals [20]. 
In the following, we will detail three approaches to the construction 
of a two-sided β-content, γ-confidence tolerance interval using Mee's 
approach [41], Hoffman–Kringle approach [42] and Liao–Lin–Iyer 
approach [43, 44]. 
Mee's approach 
In this approach, the estimation of Chi-square is based on the 
Satterthwaite’s approximation. 
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The computation of uncertainty profile is based on the β-γ-content 
tolerance interval [41]. This later is calculated according to Mee’s 
approach and can be expressed as [16, 17, 20]: 
Y� ± Ksσ�IP EQ. 7 
Where:  
 𝐾𝐾𝑠𝑠 = �
𝜐𝜐∗𝜒𝜒1;𝛽𝛽2 (ℎ)
𝜒𝜒𝜐𝜐∗;1−𝛾𝛾2
                        𝐸𝐸𝐸𝐸. 8 
Ks  is the estimation of tolerance factor which should for a bilateral 




2 EQ. 9 
And:  
σ�b
2: is the variance between laboratories. 
σ�e
2: is the variance within laboratories. 
Liao–Lin–Iyer approach 
Liao and al proposed an approach that focuses on the β-
content tolerance interval. Indeed, have used the generalized pivotal 
confidence interval and Monte Carlo simulation to estimate the β-
content tolerance intervals [43, 44]. 
We consider the case of one-way random model with balanced data; 
Note that, in order to derive a two-sided tolerance interval, we have 
to obtain a margin of statistic error D, a function of σb2 and σe2, so 
that:  
PY,�σ�e2,σ�b2{PY[Y
� −  D < Y < Y�+ D|Y,� σ�IP  ] ≥ β} = γ EQ. 10 
Where Yij~N�μ, σb2 + σe2�. Once D is obtained, the tolerance interval is 
given by:  
Y�± D EQ. 11 
We define 














�σe2 EQ. 12 
To calculate D, we must determine γ upper confidence limit for 
σ12 + σ22 using the generalized confidence interval idea. 
Once the data are obtained, compute the observed values Y� , SSb and 
SSe. Let M denote the number of simulation runs. For i=1, 2, 3,…. M. 
Then, Generate independent random variables Ab,i2~χa−12  and 
Ae,i2~χa(n−12). 













 EQ. 13 
The γ quantile of the D1,i values gives an estimate of the γ upper 
confidence limit. 
The square root of this upper confidence limit, multiplied by Z(1+β)/2 
provides a margin of error statistic D needed for computing the two-
sided β-content tolerance interval. In the above, Z(1+β)/2, denotes the 
(1+β)/2 quantile of a standard normal distribution. 
Hoffman–Kringle approach 
It’s a strategy based on the Modified Large Simple (MLS) procedure 
to compute the two-sided b-content tolerance interval in balanced 
and unbalanced one-way random models [42]. For a balanced one-
way random model, we define:  




The MLS upper confidence limit forσb2 + σe2is given by:  

































 EQ. 14 
Once the S is obtained, the β-content, γ-confidence tolerance interval 
is given by:  
Y�± Z(1+β)
2
√S EQ. 15 
Evaluation of the enumeration method 
In many classical guides, validation is habitually limited to 
calculate a set of performance criteria. But according to the 
definition of validation proposed by ISO, it must also contain a 
demonstration of the fitness of the method to a defined goal 
based on these performance criteria; therefore, uncertainty 
profile is a possible solution. It consists of a graphical decision-
making tool to help the analyst decide whether an analytical 
procedure is valid. It is obtained by simultaneously combining β-
content, γ-confidence tolerance interval and acceptability limits 
in graphical format. 
In order To demonstrate the applicability of the uncertainty profile 
strategy to the microbiological field, we evaluate the performance of 
the quantitative enumeration procedure which is selected from the 
literature [1]. In this procedure, the dosage is direct and we haven’t 
to calibration data, and so we aren’t in need of response function or 
linearity study. 
For validation standards, three concentration levels have involved in 
experiment design. Each validation sample was analyzed two times 
(n= 2) for fourteen different days (a= 14). 
RESULTS AND DISCUSSION 
At each concentration level, recovery, Bias, Standard deviation (SD) 
between and within laboratories and freedom degrees are 
calculated. All obtained results are summarized in table 1. 
 
Table 1: Statistical results in Log10 (CFU/g) 
Statistic Concentration levels 
First Second Third 
Concentrations 2.267 3.23 4.176 
Number of days (a) 14 14 14 
Number of replicates (n) 2 2 2 
Bias -0.043 0.0135 0.047 
Recovery (%) 98.11 100.42 101.12 
SD between laboratories 0.0308 0.0524 0.0711 
SD within laboratories 0.1221 0.1100 0.1044 
Freedom degree 26.74 25.75 23.98 
Lower acceptability (-λ) -0.25 Log unit -0.25 Log unit -0.25 Log unit 
Upper acceptability (+λ) 0.25 Log unit 0.25 Log unit 0.25 Log unit 
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In order to calculate the tolerance intervals, we set a value of β = 
66.7% of the content preferred to be compliant, the population of 
future measures included within the acceptance limits with confidence 
levels set at 90 % and 95 %. We expanded the value of β to 80 % and 
verified the validity of the method for the two risk values. 
As known, the uncertainty is a key parameter in the strategy of the 
uncertainty profile. Its estimation is, therefore, fundamental to the 
interpretation of the results and is quite logically becomes an 
unavoidable obligation for laboratories in the various sectors where 
quantitative analytical procedures are applied to provide analytical 
results. Indeed, since 2001, the standard ISO 17025 requires testing 
laboratories to apply procedures for the estimation of the 
uncertainty of obtained results [45, 46]. In table 2 all results about 
uncertainty, expanded uncertainty and uncertainty limits are 
presented.
 
Table 2: Point estimates of the uncertainty measurement and uncertainty limits obtained for each concentration level using the 66.7 and 80 %-
content, 90 and 95 %-confidence tolerance interval computed by Mee, Liao–Lin–Iyer (GPQ with N=100000) and Hoffman–Kringle (MLS) methods 








    (Log10 (CFU/g)) Uncertainty limit limit 
0.667 0.95 Mee 2.267 0.0810 7.1459 2.0580 2.3905 
   3.23 0.0794 4.7853 3.0802 3.4069 
   4.176 0.0833 3.9899 4.0510 4.3949 
  GPG 2.267 0.0832 7.3416 2.0534 2.3951 
   3.23 0.0809 4.8735 3.0772 3.4099 
   4.176 0.0842 4.0324 4.0492 4.3967 
  MLS 2.267 0.0820 7.2339 2.0559 2.3926 
   3.23 0.0799 4.8103 3.0793 3.4078 
   4.176 0.0833 3.9887 4.0511 4.3949 
0.667 0.90 Mee 2.267 0.0909 8.0198 2.0694 2.3791 
   3.23 0.0889 5.5046 3.0919 3.3952 
   4.176 0.093 4.4529 4.0639 4.3820 
  GPG 2.267 0.0940 8.2929 2.0641 2.3844 
   3.23 0.0912 5.4914 3.0880 3.3991 
   4.176 0.0947 4.5339 4.0610 4.3849 
  MLS 2.267 0.0919 8.1042 2.0677 2.3808 
   3.23 0.0894 5.3850 3.0910 3.3961 
   4.176 0.0931 4.4608 4.0636 4.3823 
0.8 0.95 Mee 2.267 0.1072 9.4583 2.0042 2.4443 
   3.23 0.1051 6.3337 3.0273 3.4598 
   4.176 0.1103 5.2808 3.9954 4.4505 
  GPG 2.267 0.1099 9.6937 1.9987 2.4498 
   3.23 0.1071 6.4500 3.0233 3.4637 
   4.176 0.1112 5.3240 3.9935 4.4524 
  MLS 2.267 0.1085 9.5763 2.0014 2.4471 
   3.23 0.1057 6.3679 3.0261 3.4609 
   4.176 0.1103 5.2802 3.9954 4.4505 
0.8 0.90 Mee 2.267 0.1203 10.6150 2.0192 2.4293 
   3.23 0.1176 7.0869 3.0428 3.4443 
   4.176 0.1231 5.8937 4.0124 4.4335 
  GPG 2.267 0.1242 10.9606 2.0126 2.4359 
   3.23 0.1205 7.2616 3.0379 3.4492 
   4.176 0.1255 6.0082 4.0083 4.4376 
  MLS 2.267 0.1216 10.7284 2.0170 2.4315 
   3.23 0.1183 7.1286 3.0416 3.4454 
   4.176 0.1233 5.9052 4.0120 4.4339 
 
Table 3: Uncertainty limits with difference to target values for two different values of β-content and γ-confidence 
β-content γ-confidence Target Tolerance interval with Difference to target values 
values Mee’s approach GPQ approach MLS approach 
0.667 0.95 2.267 [-0.2090;0.1235] [-0.2136;0.1281] [-0.2111;0.1256] 
3.230 [-0.1498;0.1769] [-0.1528;0.1799] [-0.1507;0.1778] 
4.176 [-0.1250;0.2189] [-0.1268;0.2207] [-0.1249;0.2189] 
0.90 2.267 [-0.1976;0.1121] [-0.2029;0.1174] [-0.1993;0.1138] 
3.230 [-0.1381;0.1652] [-0.1420;0.1691] [-0.1390;0.1661] 
4.176 [-0.1121;0.2060] [-0.1150;0.2039] [-0.1124;0.2063] 
0.8 0.95 2.267 [-0.2628;0.1773] [-0.2683;0.1828] [-0.2656;0.1801] 
3.230 [-0.2027;0.2298] [-0.2067;0.2337] [-0.2309;0.2309] 
4.176 [-0.1806;0.2745] [-0.1825;0.2764] [-0.1806;0.2745] 
0.90 2.267 [-0.2478;0.1623] [-0.2544;0.1689] [-0.2500;0.1645] 
3.230 [-0.1872;0.2143] [-0.1921;0.2192] [-0.1884;0.2154] 
4.176 [-0.1636;0.2575] [-0.1677;0.2616] [-0.1640;0.2579] 
 
The uncertainty profiles are constructed from the results in table 3 
which contain the tolerance intervals with the difference to the 
target levels. 
The upper and lower uncertainty limits expressed in absolute value 
are presented in fig. below as a function of the target values 
generated by the reference method. As can be seen from the results, 
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the method was considered valid since the uncertainty intervals 
with the difference to target value are included in the±0.25 Log unit 
acceptance limits for all levels tested. 
Legend 
The continuous gray lines are the tolerance limits computed by MLS 
method, the dashed green lines represent the uncertainty limits 
computed by GPQ method, the blue dotted lines are the upper and 
lower β-content, γ-confidence tolerance limits calculated by Mee’s 
method and the red dashed lines are set at±0.25 Log unit. 
In order to illustrate this methodology, it was applied to the 
validation of enumeration method of Enterobacteriaceae in foods. As 
indicated several times above, the uncertainty profile, directly 
reflecting the analytical procedure potential, makes possible to 




Fig. 1: Uncertainty profile of the alternative method of enumeration of Enterobacteriaceae using Mee, GPQ and MLS methods (A): profile 
carried out with β=66.7 %, γ= 90 %, (B): profile carried out with β=66.7 %, γ= 95 % 
 
 
Fig. 2: Uncertainty profile of the alternative method of enumeration of Enterobacteriaceae using Mee, GPQ and MLS methods (C): profile 
carried out with β=80 %, γ= 90 %, (D): profile carried out with β=80 %, γ= 95 % 
 
All the steps listed below have been applied successfully to evaluate 
the performance of the alternative method of enumeration. On the 
other hand, the proposed strategy allows a good estimate of 
measurement uncertainty by using validation data [1] and without 
having recourse to other experiments by using the formula equation 
(3) for estimating uncertainty based on the β-content, γ-confidence 
tolerance interval and computed by three different methods: the 
Satterthwaite’s approximation (Mee’s method) [41], the GPQ method 
(generalized pivotal confidence) [43, 44] and the MLS procedure 
(modified large simple). 
All for β=66.7 %, γ= 90% tolerance limit values are included within 
the acceptability limits, and it can be concluded that the alternative 
method is fully validated for all the three chemometric methods. 
Indeed, the tolerance intervals computed by Mee, GPQ and MLS 
methods are, as can be shown in fig.1. A, within the acceptance limits 
for all target levels. Even if we take a risk of 5 %, all tolerance limits, 
presented in fig.1. B, are always inside the acceptance limits.  
Consider that over the validation domain; the tolerance interval is 
included in the acceptability limits; the method can be declared as 
valid over this range. This can be interpreted as follows: by 
definition, the β=66.7 %, γ= 90 & 95 % tolerance limits is supposed 
to contain, on average, 66.7 % of the predicted future 
measurements. Therefore, the analyst can guarantee that, on 
average, 66.7 % of the future results will fall within the limits of this 
prediction interval. As far as this percentage is included in the 
acceptability limits, the analyst can guarantee that future 
measurements will be equivalent to those obtained by the reference 
method, with an acceptance of±0.25 Log unit. 
The other hand, we compared the results obtained from the 
uncertainty profile, with that calculated by the accuracy profile, 
each time led to the same decision even if we chose a value of±0.25 
Log unit as acceptability limits. But, our preference is for the 
uncertainty interval, because this type of strategy allows a better 
estimate of the uncertainty measurement compared to the total 
error interval. 
If the analyst wants more future measurements included in the 
limits of acceptability, there is the possibility to extend the β value to 
80%. As a result, for an acceptance of±0.25 Log unit, the method is 
not valid on all range of target levels, fig. 2, for the tolerance 
intervals Mee, MLS, and GPG for both risks 5% and 10 %. 
Otherwise, if we choose an acceptance of±0.3Log unit, the 
uncertainty limits are included in the acceptability limits; the 
method, as shown in fig. 3, can be declared as valid over this range. 
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Fig. 3: Uncertainty profile of the alternative method of enumeration of Enterobacteriaceae using Mee, GPQ and MLS methods (C): profile 
carried out with β=80 %, γ= 90 %, (D): profile carried out with β=80 %, γ= 95 %. Acceptance limits are set at±0.3 Log unit 
 
CONCLUSION 
The validation of any analytical method is the ultimate step before 
the routine use. In this work, we have demonstrated the ability of 
the uncertainty profile to be used for testing the validity of 
enumeration method which represents the first application of an 
uncertainty profile to food microbiological methods, and provides 
good estimations of the uncertainty measurements for each 
concentration level. 
The uncertainty profile is built from the β,γ-tolerance interval. Three 
chemometric methods have been used to assess the tolerance 
interval: the Satterthwaite’s approximation (Mee), the GPQ method 
(generalized pivotal confidence) and the MLS procedure (modified 
large simple). In the light of the obtained results, we have shown 
that these three statistic methods can easily be applied to evaluate 
the performance of enumeration method as well as to assess the 
uncertainty of results and led to the same decision. 
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